Tested, trusted technology.1
Next-generation ease and comfort.
You know The Vest System as a leading High Frequency Chest Wall Oscillation (HFCWO) therapy. No other device in the category has been studied as extensively or trusted by more patients.1
We asked patients and clinicians how we could make it even better, and created The Vest APX System based on their input. It combines that well-established efficacy with enhanced patient comfort and ease of use1—creating an advanced user experience designed to support daily therapy, with improved portability2 and more vest garment colors and patterns for patients to choose from.
The Vest APX System: the next generation of The Vest System from Hillrom.
Hillrom is a part of Baxter.
How do you improve an airway clearance system that already set the standard?
The Vest APX System uses the same trusted technology as The Vest System, the pioneer and leader in HFCWO therapy.
We listened to every bit of feedback we heard from clinicians and patients and got to work making it more comfortable, portable, easier to use—and easier to fit into patients’ lifestyles.*
*Compared to The Vest System, Model 105.
Slimmer, Lighter Garment
Touchscreen Interface
Smaller, Lighter Unit
Quick-attach Connections
Percentage of cystic fibrosis patients showing improvement in FVC and FEV1 regression line slopes during therapy2
Fewer acute exacerbations in bronchiectasis patients, disease specific (P = 0.007)3
Reduction in inpatient days for neuromuscular patients (P < 0.001)4
Signature CARE CONNEX Service
to support your patients and practice.
Baxter created the Care Connex Program: aimed to deliver comprehensive services at every step of the patient journey, offering new efficiencies for your practice and helping improve the therapy experience for your patients.
We work with more than a thousand leading local, regional and national companies to include commercial health plans and networks, Medicaid, Medicare, TRICARE and the Department of Veterans Affairs.
- Insurance provider services
- 24/7 clinical care with multilingual customer service and product support
- 600+ in-home licensed clinicians
- Continuing education courses
- Clinical in-home assessments, training, outcomes monitoring and reporting
- E-prescribing available (Parachute, Epic, Cerner, Allscripts and others)
Making therapy easy and more comfortable.*
More colors and patterns for patients to personalize their therapy.
Comes in sizes and styles for a broad range of patients: vest garment 16”-52”, wrap 19”-67”.
Explore the all-new Advanced Pulmonary Experience.
To discuss how The Vest APX System could benefit your patients, practice, and facility, contact your Baxter representative or fill out and submit this form.
Rx Only. For safe and proper use of product mentioned herein, please refer to the Instructions for Use or Operator’s Manual.
- Data on file at Baxter International Inc.
- Warwick W, Hansen L. The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1991; 11: 265-271.
- Basavaraj A, Choate R, Becker BC, Aksamit TR, Metersky ML; Bronchiectasis and NTM Research Registry Investigators. Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM research registry. Respir Med. 2024 Mar;223:107555. doi: 10.1016/j.rmed.2024.107555. Epub 2024 Feb 1. PMID: 38307319.
- Lechtzin N, Wolfe LF, Frick KD. The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases. Ann Am Thorac Soc. 2016 Jun;13(6):904-9. doi: 10.1513/AnnalsATS.201509-597OC. PMID: 26999271.
Baxter, Care Connex, Hillrom, and The Vest are trademarks of Baxter International Inc. or its subsidiaries. Velcro is a trademark of Velcro IP Holdings LLC.
US-FLC201-240053 [v1.0] 03/2025